| For: | Qiu Y, Xu MB, Yun MM, Wang YZ, Zhang RM, Meng XK, Ou-Yang XH, Yun S. Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells. World J Gastroenterol 2011; 17(48): 5260-5266 [PMID: 22219594 DOI: 10.3748/wjg.v17.i48.5260] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i48/5260.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Ying Qiu, Mark M. Yun, Xuebin Dong, Mingbao Xu, Ruidong Zhao, Xia Han, Erxia Zhou, Feiyu Yun, Wuyun Su, Caixia Liu, Haiyan Zhao, Xin Tong, Jin Gao, Xiaohui Ouyang, Sheng Yun. Combination of cytokine-induced killer and dendritic cells pulsed with antigenic α-1,3-galactosyl epitope–enhanced lymphoma cell membrane for effective B-cell lymphoma immunotherapy. Cytotherapy 2016; 18(1) doi: 10.1016/j.jcyt.2015.09.012
|
| 3 |
Uri Galili. Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy. Pharmaceutics 2024; 16(10) doi: 10.3390/pharmaceutics16101263
|
| 4 |
Eishiro Mizukoshi, Shuichi Kaneko. Inflammation and Immunity in Cancer. 2015; doi: 10.1007/978-4-431-55327-4_10
|
| 5 |
Yaojie Fu, Shanshan Liu, Shan Zeng, Hong Shen. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1396-4
|
| 6 |
Uri Galili. Arming Inactivated Enveloped Virus Vaccines with the GGTA1 Gene: A Potent Method for Amplification of Viral Vaccines Effectiveness and Protection Against Variants. Vaccines 2026; 14(7) doi: 10.3390/vaccines14070571
|
| 7 |
Fengzhen Mo, Dabing Xue, Siliang Duan, Aiqun Liu, Xiaomei Yang, Xiaoqiong Hou, Xiaoling Lu. Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer. Vaccine 2019; 37(7) doi: 10.1016/j.vaccine.2019.01.004
|
| 8 |
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24108598
|
| 9 |
Shasha Song, Pingfan Yuan, Peipei Li, Huaxun Wu, Jingtao Lu, Wei Wei. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma. International Immunopharmacology 2014; 22(2) doi: 10.1016/j.intimp.2014.07.007
|
| 10 |
Ying Zhang, Ingo G. H. Schmidt‐Wolf. Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy. Journal of Cellular Physiology 2020; 235(12) doi: 10.1002/jcp.29827
|
| 11 |
Clara E Jäkel, Ingo GH Schmidt-Wolf. An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells. Expert Opinion on Biological Therapy 2014; 14(7) doi: 10.1517/14712598.2014.900537
|
| 12 |
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Yasushi Uemura, Tetsuya Nakatsura. Potentiality of immunotherapy against hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(36): 10314-10326 doi: 10.3748/wjg.v21.i36.10314
|
| 13 |
Jesús Prieto, Ignacio Melero, Bruno Sangro. Immunological landscape and immunotherapy of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2015; 12(12) doi: 10.1038/nrgastro.2015.173
|
| 14 |
Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura, Norihiro Fujinami, Tetsuya Nakatsura. Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S291558
|
| 15 |
Leonard Christopher Schmeel, Frederic Carsten Schmeel, Christoph Coch, Ingo G. H. Schmidt-Wolf. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). Journal of Cancer Research and Clinical Oncology 2015; 141(5) doi: 10.1007/s00432-014-1864-3
|
| 16 |
Bruno Sangro, Daniel Palmer, Ignacio Melero. Immunotherapy of Hepatocellular Carcinoma. Hepatic Oncology 2014; 1(4) doi: 10.2217/hep.14.16
|
| 17 |
CONG CHEN, YIN-HUA MA, YA-TING ZHANG, FAN ZHANG, NING ZHOU, XIANG WANG, TAO LIU, YU-MIN LI. Effect of dendritic cell–based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis. Cytotherapy 2018; 20(8) doi: 10.1016/j.jcyt.2018.06.002
|
| 18 |
Behnoud Baradaran Noveiry, Armin Hirbod‐Mobarakeh, Nastaran Khalili, Niloufar Hourshad, Tim F Greten, Ghassan K Abou‐Alfa, Nima Rezaei. Specific immunotherapy in hepatocellular cancer: A systematic review. Journal of Gastroenterology and Hepatology 2017; 32(2) doi: 10.1111/jgh.13449
|
| 19 |
Clara E. Jäkel, Annabelle Vogt, Maria A. Gonzalez-Carmona, Ingo G. H. Schmidt-Wolf. Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors. Journal of Immunology Research 2014; 2014 doi: 10.1155/2014/897214
|
| 20 |
Uri Galili. The Natural Anti-Gal Antibody As Foe Turned Friend In Medicine. 2018; doi: 10.1016/B978-0-12-813362-0.00010-5
|
| 21 |
Uri Galili. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes. Vaccine 2020; 38(42) doi: 10.1016/j.vaccine.2020.08.032
|
| 22 |
Meng-Yu Wu, Giuo-Teng Yiang, Pei-Wen Cheng, Pei-Yi Chu, Chia-Jung Li. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. Journal of Clinical Medicine 2018; 7(8) doi: 10.3390/jcm7080213
|
| 23 |
Xiao-Bo Wang, Xi Liu, Fan-Hua Kong, Jing Cao. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology 2019; 25(27): 3649-3663 doi: 10.3748/wjg.v25.i27.3649
|
| 24 |
Uri Galili. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.746883
|
| 25 |
Mark R. Albertini, Erik A. Ranheim, Cindy L. Zuleger, Paul M. Sondel, Jacquelyn A. Hank, Alan Bridges, Michael A. Newton, Thomas McFarland, Jennifer Collins, Erin Clements, Mary Beth Henry, Heather B. Neuman, Sharon Weber, Giles Whalen, Uri Galili. Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer Immunology, Immunotherapy 2016; 65(8) doi: 10.1007/s00262-016-1846-1
|
| 26 |
Yingying Huang, Yong Huang, Jian He, Huiling Wang, Yiqun Luo, Yanmei Li, Junjie Liu, Liping Zhong, Yongxiang Zhao. PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene. Biomaterials 2019; 217 doi: 10.1016/j.biomaterials.2019.119231
|
| 27 |
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay, Ahmet Coker. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 2016; 15(3) doi: 10.1016/S1499-3872(16)60097-8
|
| 28 |
Jeong-Hoon Lee, Joon Hyeok Lee, Young-Suk Lim, Jong Eun Yeon, Tae-Jin Song, Su Jong Yu, Geum-Youn Gwak, Kang Mo Kim, Yoon Jun Kim, Jae Won Lee, Jung-Hwan Yoon. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up. Cancer Immunology, Immunotherapy 2019; 68(1) doi: 10.1007/s00262-018-2247-4
|
| 29 |
Uri Galili. Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?. Glycobiology 2016; doi: 10.1093/glycob/cww088
|
| 30 |
Uri Galili. The α-Gal Epitope (Galα1-3Galβ1-4GlcNAc) as Therapeutic Agent in Cancer Immunotherapy, Vaccine Effectiveness Amplification and Injured Tissue Regeneration. International Journal of Molecular Sciences 2026; 27(6) doi: 10.3390/ijms27062737
|
| 31 |
Shasha Song, Pingfan Yuan, Huaxun Wu, Jingyu Chen, Jingjing Fu, Peipei Li, Jingtao Lu, Wei Wei. Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells. International Immunopharmacology 2014; 20(1) doi: 10.1016/j.intimp.2014.02.027
|
| 32 |
Yasunari Nakamoto. Promising new strategies for hepatocellular carcinoma. Hepatology Research 2017; 47(4) doi: 10.1111/hepr.12795
|
| 33 |
Uri Galili, Gary L. Schaer. Lessons of Macrophage-Associated Heart Regeneration in Fish, Amphibians, and Neonatal Mice, Applied to Adult Mice: A Perspective on α-Gal Nanoparticles. International Journal of Molecular Sciences 2026; 27(4) doi: 10.3390/ijms27041950
|
| 34 |
Xiu-Rong Cai, Xing Li, Jin-Xiang Lin, Tian-Tian Wang, Min Dong, Zhan-Hong Chen, Chang-Chang Jia, Ying-Fen Hong, Qu Lin, Xiang-Yuan Wu. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review. Oncotarget 2017; 8(19) doi: 10.18632/oncotarget.15454
|
| 35 |
Shiroh Tanoue, Li-Yuan Chang, Yonghai Li, David E. Kaplan. Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects. Cellular Immunology 2015; 295(1) doi: 10.1016/j.cellimm.2015.02.008
|
| 36 |
Uri Galili, Yongxiang Zhao. Potential induction of protective anti-tumor immune response in cancer patients by oncolytic viruses containing the GGTA1 gene. European Journal of Cancer 2026; 236 doi: 10.1016/j.ejca.2026.116251
|
| 37 |
Thomas C Wirth. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies. Expert Review of Gastroenterology & Hepatology 2014; 8(1) doi: 10.1586/17474124.2014.862497
|
| 38 |
Current World Literature. Current Opinion in Allergy & Clinical Immunology 2012; 12(4) doi: 10.1097/ACI.0b013e328356708d
|